Is CVE-2020-16212 actively exploited?

CVE-2020-16212 has no public evidence of in-the-wild exploitation as of 2024-11-21.

What is the CVSS score for CVE-2020-16212?

CVE-2020-16212 has a CVSS score of 6.8 (MEDIUM severity). Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

How do I patch CVE-2020-16212?

Patch guidance is available from philips security advisories. CVEDatabase generates AI-assisted remediation guidance on demand for CVE-2020-16212.

CVE-2020-16212 - remediation guidance & executive summary

Q: Which products are affected by CVE-2020-16212?

3 products: philips patient information center ix, philips patient information center ix, philips patient information center ix.

Description

In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the product exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource. The application on the surveillance station operates in kiosk mode, which is vulnerable to local breakouts that could allow an attacker with physical access to escape the restricted environment with limited privileges.

CVSS Metrics

Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Attack Vector: physical
Complexity: low
Privileges: none
User Action: none
Scope: unchanged
Confidentiality: high
Integrity: high
Availability: high
Weaknesses: CWE-668 CWE-668

Metadata

Primary Vendor: PHILIPS
Published: 9/11/2020
Last Modified: 11/21/2024
Source: NIST NVD
Note: Verify all details with official vendor sources before applying patches.

Affected Products

philips : patient_information_center_ixphilips : patient_information_center_ixphilips : patient_information_center_ix

Remediation Guidance

Executive Summary

Cite this page

CVE-2020-16212. CVEDatabase.com. Retrieved 1 May 2026. https://cvedatabase.com/cve/CVE-2020-16212

View on NIST NVD

CVE-2020-16212 vulnerability